GI & Endoscopy

Here are two new ASCs and facilities offering GI services.

A study examined bowel cancer incidence and mortality rates in Austria over the last decade.

Canada touts one of the highest childhood-onset inflammatory bowel disease incidence rates in the world, and it's getting worse, MedPage Today reports.

Rochester, Minn.-based Mayo Clinic is testing Owlstone Medical's ATLAS Headspace Sampler and Lonestar VOC Analyzer in a clinical trial evaluating bowel preparation, Business Weekly reports.

Here are five updates on GI companies from the past week.

Megan Adams, MD, is a gastroenterologist at Ann Arbor-based Michigan Medicine Gastroenterology Clinic.

Allergan entered into a clinical trial agreement with Novartis to conduct a phase 2b study of Allergan's cenicriviroc and Novartis' lead FXR agonist in treating non-alcoholic steatohepatitis.

Researchers from the University of Nebraska-Lincoln created an autonomous colonoscopy robot, the Daily Nebraskan reports.

There's a great medical need for new therapies aimed at treating irritable bowel syndrome, according to FDA gastroenterologist Tara Altepeter, MD.

According to data released by the CDC, Crohn's disease-related hospitalizations remained stable between 2003 and 2013 despite new therapies aimed at reducing remission and hospitalizations.